To investigate whether tumour cells were present after the 8 day treatment protocol that could still respond to GCV, we assayed HSV-TK expression, which was significantly increased in LV-miniMg-∆MEF3/NF1-HSV tumour samples compared with LV-∆miniMg-HSV controls (Fig. 4i). The gene discussed is TKT; the disease is neoplasm.